Safety and Pharmacokinetic Characteristics of DKF-313

NCT02352311 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostate Hyperplasia
Healthy

Interventions

DRUG: DKF-313
DRUG: AVODART
DRUG: CIALIS

Sponsor

Dongkook Pharmaceutical Co., Ltd.